Benzinga | Oct 28, 2021 09:17AM EDT

Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $130

Credit Suisse analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $126 to $130.